The Court of Appeal on Friday rejected a bid by BGI Group subsidiaries to overturn findings that they infringed valid patents for rapid DNA sequencing held by Illumina Cambridge Ltd., holding the inventions were not obvious in light of prior research in the field.
The Court of Appeal on Friday rejected a bid by BGI Group subsidiaries to overturn findings that they infringed valid patents for rapid DNA sequencing held by Illumina Cambridge Ltd., holding the inventions were not obvious in light of prior research in the field.